Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Bristol-Myers Squibb (BMS)

Status

Completed

Conditions

Lung Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT03425825

CA209-913

Details and patient eligibility

About

Non-interventional, retrospective study of advanced SCLC patients in 4 European countries (France, Germany, Italy, and United Kingdom [UK]) with the aim to produce evidence across different SCLC treatment lines to characterize the clinical and economic burden of the disease in Europe.

Enrollment

764 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Cohort 1 and 2:

Patients 18 years of age or older at SCLC diagnosis
Confirmed diagnosis of SCLC within the patient identification period (between October 2013 and October 2015)
Initiated on first-line treatment (radiotherapy and/or chemotherapy) for their SCLC
Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first)
Signed informed consent (where required as per local requirements)

Cohort 3:

Patients 18 years of age or older at SCLC diagnosis
Confirmed diagnosis of SCLC not earlier than October 2013
Initiated on second-line treatment due to relapse after first-line therapy not later than August 2016
Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first)
Signed informed consent (where required as per local requirements)

Exclusion criteria

Participants with previous malignancies (except non-melanoma skin cancers, and in situ cancers such as the following: bladder, gastric, colon, cervical/dysplasia, melanoma, or breast) are excluded unless a complete remission was achieved at least 2 years prior to first treatment and no additional therapy is required or anticipated to be required during the study period.

Other Inclusion/Exclusion criteria may apply